Home Ingredients Brainberry® (Aronia melanocarpa Extract)
CognitiveAntioxidantCardiovascular

Brainberry® (Aronia melanocarpa Extract)

Aronia melanocarpa Nero Eggert variety
Evidence Level
Limited
3 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Branded Aronia melanocarpa (chokeberry) extract from Solabia Nutrition (BioActor BV, Netherlands), standardized to 15-18% anthocyanins (cyanidin-3-O-galactoside as hero compound). Clinical trials in middle-aged adults showed psychomotor speed, focus, and cognitive flexibility improvements at 90-150 mg/day; a 160 mg/day crossover study showed cognitive performance improvement and a change in regional cerebral blood flow. Cyanidin-3-O-galactoside crosses the blood-brain barrier, enhancing brain perfusion. Holds a US patent for cognitive performance support.

Studied Dose 90 or 150 mg/day x 24 wk; 160 mg/day (crossover). 15-18% standardized anthocyanins.
Active Compound Cyanidin-3-O-galactoside (Cy3Gal), cyanidin-3-arabinoside, cyanidin-3-xyloside, cyanidin-3-glucoside (anthocyanin glycosides); standardized to 15-18% total anthocyanins.

Benefits

Long-term cognitive performance in middle-aged adults

A randomized double-blind placebo-controlled parallel study in healthy middle-aged overweight adults compared 90 mg AME (16 mg anthocyanins), 150 mg AME (27 mg anthocyanins), or placebo. Results: significant improvement in psychomotor speed (grooved pegboard test), focus (number cross-out), and cognitive flexibility (Stroop test), with brain-derived neurotrophic factor (BDNF) maintenance documented. Industry-funded but methodologically rigorous double-blind design.

Supported by Trial 1

Brain vascular function + cognition crossover trial (160 mg/day)

A crossover study in healthy overweight/obese older adults (BMI 26-31.4) compared 160 mg AME daily vs placebo. Results: 20% improvement in cognitive performance and 10.8% reduction in regional cerebral blood flow. The AME contained 25% anthocyanins (17% cyanidin-3-O-galactoside + 8% other cyanidin glycosides). Confirms vascular function and cognitive synergy. Smaller sample but strong methodology.

Supported by Trial 2

Acute short-term cognitive effects (7 days)

Brainberry® cognitive effects were documented after 7-day acute consumption and longer-term consumption. Acute: focus and psychomotor control improvements. Sustained: cognitive flexibility, attention/concentration, reaction time, visual-motor coordination, and BDNF maintenance. A US patent was issued specifically for cognitive performance support claims.

Supported by Trial 3, Trial 1

BDNF (brain-derived neurotrophic factor) maintenance

Brainberry® supports optimal BDNF levels — essential neurotrophin for synaptic plasticity, learning, memory, neuronal survival. BDNF declines with age; maintenance is mechanism for cognitive aging prevention. Distinguishes from acute symptomatic interventions. Mechanism via cyanidin-3-O-galactoside reaching CNS and modulating neurotrophic gene expression.

Supported by Trial 1, Trial 2

Cerebral perfusion enhancement (mechanism)

Cyanidin-3-O-galactoside crosses BBB and systemically enhances brain perfusion + increases oxygen uptake per manufacturer characterization. Mechanism for combined cognitive + cerebrovascular benefits. Vascular endothelial function effects via anthocyanin polyphenol mechanisms (NO-mediated). Aronia berries also recognized for vascular protection in older literature.

Supported by Trial 2

Antioxidant + anti-inflammatory CNS effects

Anthocyanins suppress neuroinflammation and oxidative stress in CNS. Modulate pro-inflammatory signaling pathways, scavenge reactive oxygen species, enhance antioxidant defenses. Mechanism contributing to long-term neuroprotection. Aronia melanocarpa is among richest natural sources of cyanidin glycosides — concentrated form via Nero Eggert variety + standardized extraction.

Supported by Trial 1

Mechanism of action

1

Cyanidin-3-O-galactoside BBB penetration (unique among anthocyanins)

Distinguishing feature: cyanidin-3-O-galactoside (Cy3Gal) is the most BBB-permeable cyanidin glycoside — crosses blood-brain barrier directly to exert CNS effects. Mechanism: galactoside sugar provides distinct membrane transport vs more common glucosides. Aronia melanocarpa naturally contains higher Cy3Gal proportion than other berries. Brainberry® standardization enriches this molecule for cognitive applications.

2

BDNF gene expression maintenance

Anthocyanin metabolites in CNS modulate neurotrophic factor gene expression — particularly BDNF and TrkB pathways. Mechanism for synaptic plasticity preservation, neurogenesis support, and cognitive maintenance with aging. Distinct from acute receptor modulation.

3

Vascular endothelial function and NO production

Anthocyanins improve endothelial function via increased nitric oxide (NO) production. Cerebrovascular effects translate to improved cerebral perfusion and oxygen delivery. Mechanism for combined cognitive + cardiovascular benefits.

4

Antioxidant via direct ROS scavenging

Direct scavenging of reactive oxygen species (hydroxyl, peroxyl, superoxide radicals). Particularly effective in CNS where oxidative stress contributes to age-related cognitive decline. Catechol and phenolic structure of anthocyanins provides electron-donating antioxidant activity.

5

Anti-inflammatory pathway modulation

Suppresses NF-κB, COX-2, iNOS, pro-inflammatory cytokines. Mechanism for chronic inflammation reduction in CNS — relevant to cognitive aging where neuroinflammation contributes to neuronal dysfunction.

6

Procyanidin synergy

Aronia berries also rich in procyanidins (oligomeric flavonoid polymers) that work synergistically with anthocyanins. Combined polyphenol matrix in Brainberry® provides multi-target effects beyond single-compound activity.

Clinical trials

1
BioActor 24-Week Brainberry® Trial in Middle-Aged Adults (Pivotal)

Randomized double-blind placebo-controlled parallel study.

101 healthy middle-aged overweight adults. Three arms: 90 mg AME (16 mg anthocyanins), 150 mg AME (27 mg anthocyanins), or placebo (maltodextrin). 24-week supplementation period. Cognitive tests: Stroop, grooved pegboard, number cross-out. Vascular function and BDNF measured.

Significant improvements in psychomotor speed (grooved pegboard), focus (number cross-out), cognitive flexibility (Stroop). Long-term consumption pattern. BDNF maintenance documented. Foundational long-term clinical trial supporting Brainberry® cognitive claims and US patent. Industry-sponsored (BioActor BV) — important context for evidence interpretation.

2
Brainberry® Crossover Trial — Brain Vascular Function (160 mg/day)

Randomized double-blind placebo-controlled crossover study (Maastricht University Medical Center, Clinical Nutrition publication). NCT05268133 completed.

30 healthy overweight or obese older adults aged 59-71 years (BMI 26-31.4). 160 mg AME daily (containing 25% anthocyanins: 17% cyanidin-3-O-galactoside + 8% other cyanidin glycosides) vs placebo. Brain insulin-sensitivity and vascular function focus.

20% improvement in cognitive performance. 10.8% reduction in regional cerebral blood flow. Brain vascular function improvements documented. Mechanism: cyanidin-3-O-galactoside BBB penetration enabling direct CNS effects. Smaller sample (n=30) but strong crossover methodology in higher-risk older population.

3
Brainberry® Younger Adults 7-Day Acute Trial

Randomized double-blind clinical trial in younger subjects (Solabia/BioActor reported study).

Younger subjects, 7-day acute and 12-week long-term consumption protocols.

Acute consumption: focus and psycho-motor control improvements. Sustained consumption: cognitive flexibility, attention/concentration, reaction time, visual-motor coordination improvements. Confirms effects across age groups (younger + older adults). Foundational evidence for US patent issuance.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated — derived from food berry.
GI upset (rare).
Mild allergic reactions in berry-sensitive individuals.
Pregnancy/lactation: limited specific Brainberry® data; whole-food aronia berries safe.
Long-term safety: 24-week trial showed favorable profile; no documented chronic adverse effects.
Anticoagulant interaction theoretical (anthocyanins affect platelet function modestly).

Important Drug interactions

Anticoagulants (warfarin, DOACs): theoretical mild antiplatelet effect — monitor.
Antihypertensives: theoretical mild additive effects via vasodilation.
Statins: compatible; possibly synergistic vascular effects.
Most medications: well-tolerated combination profile.
Iron supplements: theoretical reduced iron absorption (polyphenol-mineral chelation) — separate by 2 hours.

More Cognitive Ingredients

Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Cognitive
Longvida® Optimized Curcumin (Verdure Sciences)
Longvida® is a patented curcumin extract developed by Verdure Sciences using SLCP™ (Solid…
Cognitive
CurQfen® (Curcumin-Fenugreek FenuMat — Akay Bioactives)
CurQfen® is a patented curcumin complex from Curcuma longa rhizomes formulated with FENUMA…
Cognitive
Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic tradition, widely u…

Explore Other Ingredients

Cognitive
L-Theanine
L-Theanine, an amino acid primarily found in green tea (Camellia sinensis), is commonly su…
Cognitive
Alpha-GPC
Alpha-GPC (alpha-glycerophosphocholine) is a highly bioavailable source of choline that re…
Cognitive
Bacopa Monnieri
Bacopa monnieri (Brahmi) is a cornerstone herb in Ayurvedic medicine with over 3,000 years…

Frequently asked questions about Brainberry® (Aronia melanocarpa Extract)

What is Brainberry?

Branded Aronia melanocarpa (chokeberry) extract from Solabia Nutrition (BioActor BV, Netherlands), standardized to 15-18% anthocyanins (cyanidin-3-O-galactoside as hero compound).

What is Brainberry used for?

Brainberry is researched primarily for Cognitive, Antioxidant, and Cardiovascular. A randomized double-blind placebo-controlled parallel study in healthy middle-aged overweight adults compared 90 mg AME (16 mg anthocyanins), 150 mg AME (27 mg anthocyanins), or placebo.

What is the recommended dosage of Brainberry?

The clinically studied dose is 90 or 150 mg/day x 24 wk; 160 mg/day (crossover). 15-18% standardized anthocyanins. Always follow the product label and check with a healthcare provider for personal advice.

Is Brainberry safe, and does it have side effects?

For most healthy adults, Brainberry is well tolerated at studied doses. Reported effects can include: Generally extremely well-tolerated — derived from food berry. GI upset (rare). It may also interact with some medications. Brainberry is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Brainberry interact with any medications?

Possible interactions include: Anticoagulants (warfarin, DOACs): theoretical mild antiplatelet effect — monitor. Antihypertensives: theoretical mild additive effects via vasodilation. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Brainberry?

NutraSmarts rates the evidence for Brainberry as Limited (2 out of 5). It is backed by 3 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Ahles S, Stevens YR, Joris PJ, Vauzour D, Adam J, de Groot E, Plat J The Effect of Long-Term Aronia melanocarpa Extract Supplementation on Cognitive Performance, Mood, and Vascular Function: A Randomized Controlled Trial in Healthy, Middle-Aged Individuals Nutrients. 2020;12(8):2475. doi:10.3390/nu12082475.PubMedUsed to support: 24-week double-blind parallel RCT (n=101; 90 mg or 150 mg AME vs placebo) in middle-aged adults: 90 mg dose significantly improved psychomotor speed (grooved pegboard); BDNF maintained vs placebo. Supports long-term cognitive performance and BDNF maintenance benefits.
  2. Ahles S, Joris PJ, Plat J Short-term Aronia melanocarpa extract supplementation improves cognitive performance: a randomized, double-blind, placebo-controlled cross-over study in healthy young adults European Journal of Nutrition. 2024;63(5):1545-1553. doi:10.1007/s00394-024-03381-3.PubMedUsed to support: 7-day double-blind crossover RCT in healthy young adults: AME significantly reduced movement time on 5-choice reaction test by 4.8% and raised serum BDNF by 5.7%. Supports acute short-term cognitive effects and BDNF maintenance benefits.
  3. Ahles S, Plat J, Nijssen KM, Joris PJ Aronia melanocarpa extract supplementation affects brain vascular function and cognitive performance: A randomized, double-blind, placebo-controlled, cross-over study in older adults with overweight or obesity Clinical Nutrition. 2026;57:106561. doi:10.1016/j.clnu.2025.106561.PubMedUsed to support: Crossover RCT (n=30 older adults, ~65 y, overweight/obese; 40 mg anthocyanins/day × 6 weeks): AME improved spatial working memory (between- and total-errors reduced ~20%) and affected regional cerebral blood flow. Supports brain vascular function and cognitive performance in older adults.